Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Int J Nanomedicine. 2019;14:5679–5690.The authors of this paper have advised that by their mistake, they omitted an important note from the Acknowledgments section on page 5688.Read the original article
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/089b3c9254d64f899ca5adba19a3ed48 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!